Federal Register Final rule: FDA is adopting as a final rule, without change, the interim final rule that issued regulations permitting FDA Center directors to grant exceptions or alternatives to certain regulatory labeling requirements applicable to human drugs, biological products, or medical devices that are or will be included in the Strategic National Stockpile. To view this final rule, click here.
